Strong inverse correlation between serum TPO level and platelet count in essential thrombocythemia

Naoto Tomita*, Shigeki Motomura, Rika Sakai, Katsumichi Fujimaki, Juichi Tanabe, Hitoshi Fukawa, Hiroshi Harano, Heiwa Kanamori, Kouji Ogawa, Hiroshi Mohri, Atsuo Maruta, Fumio Kodama, Yoshiaki Ishigatsubo, Tomoyuki Tahara, Takashi Kato


研究成果: Article査読

13 被引用数 (Scopus)


Serum thrombopoietin (TPO) levels in 50 essential thrombocythemia (ET) patients were measured using a highly sensitive sandwich ELISA. In nine cases, TPO levels were measured at two points with different platelet counts. ET patients showed significantly higher serum TPO levels (n = 59, 2.70 ± 2.74 fmol/mL, P < 0.0001) than those of normal individuals (n = 29, 0.83 ± 0.36 fmol/mL). Twenty-three previously untreated ET patients also showed significantly higher serum TPO levels (1.33 ± 0.75 fmol/mL, P = 0.0066) than normal individuals. Extremely high serum TPO levels (5.46 ± 3.68 fmol/mL) were observed in ET patients with normal platelet counts. Furthermore, a strong inverse correlation was found between serum TPO levels and platelet counts in ET patients (R = -0.729, P < 0.0001). This inverse correlation also held for each of nine cases with two-point TPO measurements. In the clinical course of ET, megakaryocyte mass may parallel the platelet mass before and after chemotherapy. Although it is unknown whether overproduction of TPO exists or not in ET, total platelet and megakaryocyte mass, i.e., the total number of c-Mpl, may play a role to regulate serum TPO levels. (C) 2000 Wiley-Liss, Inc.

ジャーナルAmerican Journal of Hematology
出版ステータスPublished - 2000

ASJC Scopus subject areas

  • 血液学


「Strong inverse correlation between serum TPO level and platelet count in essential thrombocythemia」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。